Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
NCT ID: NCT04812795
Last Updated: 2023-11-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2214 participants
INTERVENTIONAL
2021-09-08
2022-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
NCT05499520
Individually Tailored and Integrated Social Support Network for Tobacco Cessation
NCT03152253
Web Assisted Tobacco Intervention With Community Colleges
NCT01692730
Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.
NCT04594109
Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA
NCT01516632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Culturally tailored (Non-smokers)
The anti-smoking and anti-industry messages will be culturally tailored to specifically reach out to young adult SMW. They will receive only messages that are culturally tailored at baseline and weeks 1, 2, and 3.
Culturally tailored anti-smoking messages: Anti-smoking messages that are culturally tailored for sexual minority women.
Culturally tailored anti-smoking messages
Anti-smoking messages that are culturally tailored for sexual minority women.
Non-culturally tailored (Non-smokers)
The anti-smoking and anti-industry messages will not be culturally tailored. They will receive only messages that are not culturally tailored at baseline and weeks 1, 2 and 3.
Non-culturally tailored interventions: Anti-smoking messages that are not culturally tailored for sexual minority women.
Non-culturally tailored interventions
Anti-smoking messages that are not culturally tailored for sexual minority women.
Culturally Tailored (Smokers)
The anti-smoking and anti-industry messages will be culturally tailored to specifically reach out to young adult SMW. They will receive only messages that are culturally tailored at baseline and weeks 1, 2, and 3.
Culturally tailored anti-smoking messages: Anti-smoking messages that are culturally tailored for sexual minority women.
Culturally tailored anti-smoking messages
Anti-smoking messages that are culturally tailored for sexual minority women.
Non-culturally Tailored (Smokers)
The anti-smoking and anti-industry messages will not be culturally tailored. They will receive only messages that are not culturally tailored at baseline and weeks 1, 2 and 3.
Non-culturally tailored interventions: Anti-smoking messages that are not culturally tailored for sexual minority women.
Non-culturally tailored interventions
Anti-smoking messages that are not culturally tailored for sexual minority women.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Culturally tailored anti-smoking messages
Anti-smoking messages that are culturally tailored for sexual minority women.
Non-culturally tailored interventions
Anti-smoking messages that are not culturally tailored for sexual minority women.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Woman
* Identifies as a sexual minority (any sexual orientation other than heterosexual)
* Lives in the United States
* Able to take surveys in English
Exclusion Criteria
* Men
* Heterosexual
* Lives outside the United States
* Unable to take survey in English
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Michigan State University
OTHER
Harvard School of Public Health (HSPH)
OTHER
Stanford University
OTHER
Dana-Farber Cancer Institute
OTHER
Fenway Community Health
OTHER
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andy Tan
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zulkiewicz BA, Chen JT, Hanby EP, Ramanadhan S, Obedin-Maliver J, Lunn MR, Scout NFN, Gordon B, Applegate J, Machado A, Viswanath K, Potter J, Liu S, Tan ASL. Anti-industry beliefs and attitudes mediate the effect of culturally tailored anti-smoking messages on quit intentions among sexual minority women. Sci Rep. 2024 Nov 15;14(1):28084. doi: 10.1038/s41598-024-78207-7.
Tan ASL, Chen JT, Keen R, Scout N, Gordon B, Applegate J, Machado A, Hanby E, Liu S, Zulkiewicz B, Ramanadhan S, Obedin-Maliver J, Lunn MR, Viswanath K, Potter J. Culturally Tailored Anti-Smoking Messages: A Randomized Trial With U.S. Sexual Minority Young Women. Am J Prev Med. 2024 May;66(5):840-849. doi: 10.1016/j.amepre.2023.12.001. Epub 2023 Dec 7.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
843579
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.